CHEMICAL CONSTITUENTS OF THE ANTIDIABETIC PLANT RAVENALA MADAGASCARIENSIS
HTML Full TextCHEMICAL CONSTITUENTS OF THE ANTIDIABETIC PLANT RAVENALA MADAGASCARIENSIS
H. Ramiarantsoa 1*, P. A. Yao-Kouassi 1, C. Kanko 2, K.M. Assi 1, A. L. Djakoure 1 and F. Z. Tonzibo 1
Laboratoire de Chimie Organique Biologique 1, Laboratoire de Chimie Organique Structurale 2, Unité de Formation et de Recherches des Sciences des Structures de la Matière et de Technologie (UFR-SSMT), Université Félix Houphouët-Boigny Côte d’Ivoire.
ABSTRACT:Ravenala madagascariensis Sonn. is one of the most popular medicinal plants in Madagascar, India and several African countries. It is used in the treatment of many diseases, and particularly in those of diabetes. The duration of treatment, often for life, and its relatively high cost for certain social categories, constrain more and more patients to use this plant. Its chemical constituents were still little studied and this problem could create significant damage in case of intoleranceor abuse during its use.The present study undertaken on the leaves of Ravenala madagascariensis, led to the isolation and structural elucidation of two new compounds (1 and 2), together with the known cycloartanol triterpene (3) which was isolated for the first time from this plant. Their structures were elucidated as (2E, 7R, 11R) phytyl-3, 7, 11, 15-tetramethylhexadec-2-enyl pentadecanoate (1) and (24S, 31S)-cycloartan-31, 32-diol (2). Structural determinations were made on the basis of analysis of 1D and 2D-NMR spectroscopic data. The complete 1H and 13C resonance assignments were also carried out by using 1H-1H COSY, HSQC, NOESY and HMBC experiments
Keywords:
|
Musaceae, Phytylester,
Cycloartan-diol. Ravenala madagascariensis Sonn.
INTRODUCTION: Ravenala madagascariensis Sonn. belongs to the family Musaceae. Commonly known as Traveler’s tree, it is endemic to Madagascar and often found cultivated anywhere in the world as an ornamental plant. It is widely used in traditional medicine in the treatment of diarrhea, hypertension 1, edema 2, kidney stone and diabetes 3, 4. The seeds are also reported to be antiseptic 4.
The ethanolic and aqueous extracts of the leaves were proven to have In vitro and In vivo antidiabetic activity on alloxan induced diabetic rats 5. In a previous paper, we reported the occurrence of the β-sitosteryl-D-glucoside in the leaves, and its complete 1H and 13C resonance assignments 6.
In this report, we investigated the hexane extract of the leaves of Ravenala madagascariensis. It led to the isolation and structural elucidation of two new compounds named (2E, 7R, 11R)-phytyl-3, 7, 11, 15-tetramethylhexadec-2-enyl pentadecanoate (1), (24S, 31S)-cycloartan-31, 32-diol (2), along with the known triterpene cycloartanol (3). Their complete 1H and 13C resonance assignments were carried out. Cycloartanol was reported in the literature as having antidiabetic activity 7, 8.
MATERIALS AND METHODS:
General:
The separation and isolation process were made using column chromatography. Silica gel 60 (230-400 mesh, Merck), neutral alumina (150 mesh, Sigma-Aldrich) and Sephadex LH 20 (Pharmacia LKB) were used as stationary phase. Analytical thin layer (TLC) chromatography aluminium sheets of silica gel 60 F254 (Merck) were used to control the fraction’s content. Compounds’ revelation was made before heating at 120°C by spraying the TLC with sulfuric vanillin after detection under an UV lamp. NMR spectra were recorded on a spectrometer Bruker Avance DRX-500 at 500 MHz (1H) and 125 MHz (13C); chemical shifts are in ppm with TMS as internal standard. The melting points were determined with a Kofler block and were uncorrected. The MS were recorded on a spectrometer Micromass Q-TOF Micro-Instrument (Manchester). Optical rotation was measured with an electronic polarimeter Polartronic-D (Schmidt + Haensch).
Plant material:
The leaves of Ravenala madagascariensis Sonn. were collected in Abidjan, Ivory Coast , during June 2010 and authenticated by Pr. L. Aké Assi of the University Félix Houphouët-Boigny, Cocody, Abidjan. Voucher specimens (n°21052) are deposited at the Herbarium of the “Centre National de Floristique” of this University.
Extraction and isolation:
Air dried and powdered leaves of Ravenala madagascariensis (1090 g) were extracted three times with EtOH – H2O (8 : 2) at room temperature for 48 hours, each. After filtration and evaporation of the solvent, the residue (90 g) was partitioned between n-hexane and H2O. After decantation and evaporation of the solvent, the hexane extract (24 g) was obtained and aqueous phase was still extracted three times with EtOAc for other investigation.
The hexane extract of the leaves of Ravenala madagascariensis was fractionated by dry flash silica gel chromatography using a gradient of methylene chloride in hexane at 10% increment as eluent. The fractions (20 ml each) obtained on elution with methylene chloride pure were separated by silica gel column chromatography eluted with 20% methylene chloride in hexane. The purification of the compound 1 was finally made with a neutral alumina column chromatography using 5% dichloromethane in hexane.
It was isolated as an oily compound (7 mg). The 50-60% methylene chloride in hexane fractions presented crystals. They were collected and purified on a silica gel column chromatography using 40% methylene chloride in hexane. The compound 2 was isolated as a white powder (5 mg). The 30-40% methylene chloride in hexane fractions were rechromatographied on a neutral alumina column eluted with 30% methylene chloride in hexane to afford compound 3 (5 mg).
(2E, 7R, 11R) – Phytyl - 3, 7, 11, 15 –tetra methylhexadec-2-enyl pentadecanoate (1):
Pale yellow oil, +21.37 (c 0.23, CHCl3), APCI MS m/z 521.9245 [M+H]+, 379, 213, 155. TOF MS (EI+) m/z(%) 113 (24), 156 (22), 184 (37), 212 (36), 256 (100), 310 (40). 1H (500 MHz, CDCl3) and 13C (125 MHz, CDCl3) (see table 1).
(24S, 31S)-Cycloartan-31, 32-diol (2):
White amorphous powder, mp.193-195, -32.7 (c 0.16, CHCl3). TOF MS (EI+): m/z 473.7912 [M+H]+, 429 (45), 355 (100), 341 (28), 327 (16), 175 (22), 124 (41). 1H (500 MHz, CDCl3) and 13C (125 MHz, CDCl3) NMR data, (see Table 2).
Cycloartanol (3):
White amorphous powder: TOF MS (EI+): m/z 428.4120 [M]+. . 1H (500 MHz, CDCl3): δ 3.29 (1H, dd, Jaa = 11.3 Hz and Jae = 4.5 Hz, H-3), 1.31 (1H, m, H-5), 1.52 (2H, m, H-8 and H-17), 1.37 (1H, m, H-20), 1.53 (1H, m, H-25), 1.57 (1H, m, ½ H2-1), 1.25 (1H, m, ½ H2-1), 1.76 (1H, m, ½ H2-2), 1.59 (1H, m, ½ H2), 1.60 (1H, m, ½ H2-6), 0.80 (1H, m, ½ H2-6), 1.90 (1H, m, ½ H2-7), 1.30 (3H, m, ½ H2-7 and H2-23), 2.00(1H, m, ½ H2-11), 1.11 (1H, m, ½ H2-11), 1.63 (2H, m, H2-12), 1.37 (2H, m, ½ H2-15 and ½ H2-16), 0.99 (1H, , m, ½ H2-15), 1.15 (3H, m, ½ H2-16 and H2-24), 1.28 (2H, m, H2-22), 0.97 (3H, s, H3-18), 0.90 (3H, d, J =5.6 Hz, H3-21), 0.87 (6H, d, J = 7 Hz, H3-26 and H3-27), 0.9 (3H, s, H3-28), 0.82 (3H, s, H-29), 0.97 (3H, s, H3-30), 0.55 (1H, d, J = 5 Hz, ½ H2-19), 0.33 (1H, d, J = 5 Hz, ½ H2-19). 13C (125 MHz, CDCl3): δ 31.9 (C-1), 30.3(C-2), 78.8(C-3), 40.4 (C-4), 47;1 (C-5), 21.1 (C-6), 28.1 (C-7), 48.0 (C-8), 20.0 (C-9), 26.0 (C-10), 26.4 (C-11), 32.8 (C-12), 45.2 (C-13), 48.8 (C-14), 36.4 (C-15), 24.1 (C-16), 52.4 (C-17), 18.0 (C-18), 29.9 (C-19), 36.1 (C-20), 18.3 (C-21), 35.5 (C-22), 24.7 (C-23), 39.5 (C-24), 28.0 (C-25), 22.6 (C-26), 22.8 (C-27), 19.3 (C-28), 14.0 (C-29), 25.4 (C-30).
RESULTS AND DISCUSSION:
The 1H NMR spectrum of 1 showed signals of four secondary methyl groups at δ 0.85 (d, 3H), 0.86 (d, 3H), 0.87 (d, 6H); a triplet of a primary methyl group at δ 0.89; resonances for an allylic methyl at 1.65 ppm, a vinyl proton at δ 5.34 and two protons of a -CH2-O- group at δ 4.59 (d). Furthermore, many overlapping methylene protons at δ 1.28 characteristics of long chain fatty acids were observed. The 13C NMR spectrum of 1 exhibited resonances of many methylene carbons between δ 29.1 and 29.7 ppm which matched well with the presence of a long chain fatty acids deduced from the analysis of the 1H NMR data.
The resonances of a carbonyl carbon of an ester at δ 173.9; those of olefinic carbons at δ 142.3 and 118.1; and finally the signal of an oxymethylene carbon at δ 61.2 indicated that 1 could be an ester of the linear diterpenephytol (2E, 7R, 11R)-3, 7, 11, 15 - tetramethyl – 2 – hexadecen – 1 - ol 9.The structure of the ester was deduced from the observed fragments of the mass spectrum. Its positive APCI MS showed a quasi-molecular ion peak at m/z 521.9158 [M+H]+, which in accordance with NMR data enable the molecular formula C35H68O2, accounting for two degrees of unsaturation. As the phytol has already the molecular formula C20H40O, the other moiety of the phytylester might be the radical C15H29. So, the compound 1 should have the following structure. (Figure 1)
FIGURE 1: CHEMICAL STRUCTURE AND MASS FRAGMENTATIONS OF 1.
In the TOF-MS (EI+) spectrum of 1, the base peak at m/z 255 resulted from the loss of the radical C19H37 from the molecular ion at m/z 520. An allylic fragmentation gave peaks at m/z 310 and 212 after proton transfer and. fragments at m/z 379, 212, 184,156, 113 confirmed the above structure. The COSY spectrum led to the determination of different partial structures of 1; most of them were shown in Figure 2.
The HMBC spectrum showed a long range correlation between the carbon of the ester carbonyl at δ 173.9 (C-1’) and both methylene carbinyl protons at δ 4.59 (H-1) and methylene protons at α position of the carbonyl δ 2.29 (H-2’). These correlations justified the attachment of the
fatty ester to the position 1 of the phytol. The position of the double bond was given from the correlations between the protons of the methylene oxide -CH2-O- and those of the olefinic carbons at δ 118.2 (C-2) and δ 142.6 ppm (C-3). Other significant HMBC correlations were shown in Figure 2.
The configuration of the double bond and those of the asymmetric carbons C-7 and C-11 were deduced from the comparison of the chemical shift values of C-2, C-3, C-7 and C-11 with those of phytol and other phytol fatty esters reported in the literature 9-11. The complete 1H and 13C resonance assignments were achieved from the analysis of 1H-1H COSY, HSQC and HMBC NMR correlations. The results are recorded in the Table I. Therefore, compound 1 was identified as (2E, 7R, 11R) - phytyl - 3, 7, 11, 15 - tetramethyl hexadec-2-enyl pentadecanoate. The NMR spectral data were listed in Table 1.
FIGURE 2: SELECTED 1H-1H COSY (BOLD LINE) AND HMBC CORRELATIONS (ARROW) OF 1.
TABLE 1: NMR SPECTRAL DATA OF COMPOUND 1 IN CDCl3
Position | Type | δ 1H (m, J in Hz) | δ13C | HMBC (HC) |
1 | CH2-O | 4.59 (d, 7.1) | 61.2 | C2, C3, C1’ |
2 | CH= | 5.34 (t, 7.1) | 118.1 | C4, C17 |
3 | C | 142.3 | ||
4 | CH2 | 2.00 (m) | 39.8 | C5, C17 |
5 | CH2 | 1.42 (m) | 24.8 | C4, C6 |
6 | CH2 | 1.27 (m); 1.08 (m) | 36.6 | |
7 | CH | 1.39 (m) | 32.8 | C6, C8, C18 |
8 | CH2 | 1.39 (m); 1.27 (m) | 37.3 | |
9 | CH2 | 1.20 (m) | 24.4 | |
10 | CH2 | 1.39 (m); 1.27 (m) | 37.4 | |
11 | CH | 1.39 (m) | 32.7 | C10, C12, C13, C19 |
12 | CH2 | 1.39 (m); 1.27 (m) | 37.3 | |
13 | CH2 | 1.34 (m) | 24.4 | |
14 | CH2 | 1.15 (m) | 39.3 | |
15 | CH | 1.52 (m) | 27.9 | C13, C14, C16/20 |
16 | CH3 | 0.87 (d, 3.4) | 22.7 | C14, C15 |
17 | CH3 | 1.65 (s) | 16.3 | C4 |
18 | CH3 | 0.86 (d, 2.4) | 19.7 | C6, C7, C8 |
19 | CH3 | 0.85 (d, 2.7) | 19.7 | C10, C11, C12 |
20 | CH3 | 0.87 (d, 3.4) | 22.6 | C14; C15 |
1’ | C=O | 173.9 | ||
2’ | CH2 | 2.29 (t, 7.5) | 34.4 | C1’, C3’, C4’ |
3’ | CH2 | 1.59 (m) | 25.0 | C1’, C2’, C5’ |
4’ | CH2 | 1.28 (m) | 29.5 | |
5’-12’ | CH2 | 1.28 (m) | 29.1-29.7 | |
13’ | CH2 | 1.28 (m) | 31.9 | |
14’ | CH2 | 1.30 (m) | 22.7 | C15’ |
15’ | CH3 | 0.88 (t, 3.6) | 14.1 | C13’, C14’ |
Compound 2 was isolated as white powder, Mp. 193-195. Its TOF MS (EI+) showed a pseudo molecular ion [M+H]+ at m/z 473.7912 compatible with the molecular formula C32H56O2. The 1H-NMR spectrum displayed signals of a methine (δ 3.29, m) and methylene protons (δ 3.65, dd, J=6.5 and 6.7 Hz) attached to carbons bearing hydroxyl groups, four tertiary methyls at δ 0.82 (3H), 0.90 (3H) and 0.97 (6H), three secondary methyls at δ 0.81 (3H) and 0.87 (6H) and a pair of doublets indicative of a cyclopropane ring bearing two non-equivalent protons (δ 0.33, d, J=5 Hz and δ 0.55, d, J=5 Hz).
The 13C-NMR spectrum presented 32 signals and its analysis corroborated the above 1H-NMR data. Furthermore it showed the resonances of five quaternary carbons, six methines and eleven methylenes. These analyses suggested that compound 2 should be a cycloartan-dioltriterpenewith 32 carbons. The 1H-1H COSY spectrum revealed a correlation between the methine proton signals at δ 1.56, δ 3.29 and that of the methylene protons at δ 3.65, suggesting the presence of the partial structure -CH–CHOH-CH2OH. The compound 2 had already seven methyl groups as in a cycloartane triterpene skeleton, so this partial structure might be located on the side chain and the compound should derive from 24-ethyl cycloartane type triterpenoids 12, 13. This hypothesis agreed with the observed EISM fragmentations: the peak at m/z 429 was obtained by the loss of the isopropyl radical of the side chain from the molecular ion at m/z 472; the base peak at m/z 355 derived from the loss of the radical C6H1302 by cleavage between C-23 and C-24.
The fragment peak at m/z 124 resulting from a characteristic fragmentation of cycloartane type triterpene 14, 15, indicated the absence of hydroxyl group on the A ring of the compound (Figure 3). The fragment at m/z 175 obtained from the successive loss of the fragment at m/z 124 and the side chain (C10H21O2) from the molecular ion peak at m/z 472, supported the presence of the hydroxyl groups in the side chain.
FIGURE 3: CHEMICAL STRUCTURE AND MASS FRAGMENTATIONS OF COMPOUND 2
The determination of the relative stereochemistry of 2 was established by analysis of the NOESY spectrum. The cross-peaks between H3-28 and H-8; H-8 and H-19β (δ 0.55); H-8 and H3-18; H3-18 and H-20; H-20 and H-24; H-24 and H-31, suggested the β-orientation of these protons. Further correlations observed between H3-29 and H-5; H-5 and H3-30; H3-30 and H-17; H-17 and H3-21, indicated their α-orientation. So, the configurations at C-24 and C-31 were determined to be 24S and 31S on the basis of the NOESY correlations (Figure 4). Compound 2 was then finally identified as (24S, 31S)-cycloartan-31, 32-diol (2) (Figure 5).
FIGURE 4: SELECTED NOESY CORRELATIONS OF 2
FIGURE 5: CHEMICAL STRUCTURE AND MAIN HMBC CORRELATIONS OF 2.
Regarding the NMR resonance assignments, we analyzed the 2D-NMR data spectra. In the HMBC spectrum were observed correlations between the signals of H-19 and those of two methylene carbons at 31.9 and 26.4 ppm (C-1 or C-11), as well as to those of two methine carbons at 47.1 and 48.0 ppm (C-5 or C-8). They also correlated with the signal of a quaternary carbon situated at δ 19.9 which could correspond to C-9 or C-10. The chemical shift of the methine proton at 1.31 ppm was assigned to H-5 on the basis of its signal correlation with that of C-1. This differentiated C-5 to C-8 and C-1 to C-11. The methylene carbon resonating at 22.7ppm was assigned to C-2 because of the correlation of its proton signal (δ 1.29) to that of C-1 and those of two quaternary carbons attributed to C-4 and C-10.
This removed the ambiguity between the assignments of C-9 and C-10. The signal of a methylene carbon at δ 30.3 was assigned to C-3 on the basis of its proton correlations (δ 1.77) to C-1 and C-4. The signals of the methyl protons at 0.82 and 0.97 ppm were assigned respectively to H-28 and H-29 because of their correlations with both C-4 and C-5. Furthermore, the correlation between the signal of H-29 and that of a methyl carbon at δ 22.8 attributed to C-28 confirmed the location of the two methyl groups at C-4. The β position of the methyl 28 was determined by its NOESY correlation with H-8 (Figure 4) and this facilitated the assignments of H-28 and H-29.
The HMBC spectrum showed correlationsof both H-5 an H-8 signals to that of a methylene carbon located at δ 21.1, assigned to C-6. The signal of H-8 correlated with that of a methyl carbon attributed to C-30. The methylene proton signals at δ 1.10 and 1.07 correlating with C-6 and C-8 were assigned to H-7. The signal of H-8 correlated also with that of a methylene carbon (δ 35.5), assigned to C-15.
Its corresponding proton signal (δ 1.29) correlated with that of another methylene carbon (δ 29.7), attributed to C-16. The signals of two angular methyl protons at δ 0.90 (H-30) and δ 0.97 assigned to H-18 because of their correlations with two quaternary carbon peaks located at 45.2 and 48.8 ppm, were attributed respectively to C-13 and C-14.
Furthermore, the correlations between H-18 and both a methylene carbon signal at 32.8 ppm and that of a methine carbon at 52.4 ppm were assigned respectively to C-12 and C-17. Concerning the side chain, the HMBC correlations between the methine proton signal at δ 1.37 and that of C-16 on one side and that of a methyl proton at δ 0.87 and C-17 on the other side, allowed to assign them respectively to H-20 and H-21. The methylene proton at δ 1.30 was attributed to H-22 on the basis of its correlation with C-20. It was also connected with a methylene carbon signal at δ 26.0 assigned to C-23 because of its correlations with both H-22 and the oxymethine proton at δ 3.29 corresponding to H-31.
TABLE 2: NMR SPECTRAL DATA OF THE COMPOUND 2 IN CDCl3
Position | Type | δ1H (m, J in Hz) | δ13C | HMBC (HC) |
1 | CH2 | 1.56 (m)
1.26 (m) |
31.9 | C10, C19
C1, C19 |
2 | CH2 | 1.29(m) | 22.7 | C1, C4, C10 |
3 | CH2 | 1.77 (m)
1.58 (m) |
30.3 | C1, C4, C10
C1, C10 |
4 | C | 40.4 | ||
5 | CH | 1.31 (m) | 47.1 | C1, C4, C6, C10, C19 |
6 | CH2 | 1.60 (m)
0.82 (m) |
21.1 | C5, C10
C4, C10 |
7 | CH2 | 1.10 (m)
1.07 (m) |
26.0 | C5, C8, C10, C19
C6 |
8 | CH | 1.52 (m) | 48.0 | C6, C9, C13, C15, C19, C30 |
9 | C | 20.0 | ||
10 | C | 25.7 | ||
11 | CH2 | 2.00(m)
1.14 (m) |
26.4 | C9, C10, C12, C19
C12, C19 |
12 | CH2 | 1.63(m) | 32.8 | C9, C11, C13, C14, C17, C18 |
13 | C | 45.2 | ||
14 | C | 48.8 | ||
15 | CH2 | 1.29 (m) | 35.5 | C8, C13, C16, C30 |
16 | CH2 | 1.27 (m) | 29.7 | C14, C17, C20 |
17 | CH | 1.57 (m) | 52.4 | C22 |
18 | CH3 | 0.97 (s) | 18.0 | C12, C13, 14, C17 |
19 | CH2 | 0.55 (d, 5)
0.33 (d, 5) |
29.9 | C1, C5, C8, C9, C11 |
20 | CH | 1.37 (m) | 36.1 | C16 |
21 | CH3 | 0.87 (d, 6.6) | 18.3 | C17 |
22 | CH2 | 1.89 (m)
1.30 (m) |
28.1 | C13
C13, C20, C23, C24, C31 |
23 | CH2 | 1.33 (m) | 26.0 | C22, C31 |
24 | CH | 1.56 (m) | 28.0 | C23, C31 |
25 | CH | 0.98 (m) | 25.4 | C27, C31 |
26 | CH3 | 0.87 (d, 2.0) | 18.0 | C27, C31 |
27 | CH3 | 0.81 (d, 2.0) | 14.0 | C25, C31 |
28 | CH3 | 0.82 (s) | 14.0 | C4, C5 |
29 | CH3 | 0.97 (s) | 22.8 | C4, C5, C28 |
30 | CH3 | 0.90 (s) | 19.3 | C8, C13, C14, C15, C17 |
31 | CHOH | 3.29 (m) | 78.8 | C23, C24, C25, C26, C27 |
32 | CH2OH | 3.65 (dd, 6.5 and 6.7) | 63.1 | C23 |
The correlation of C-31 and the signals of two methine protons at δ 1.56 and δ 0.98, gave the assignments of H-24 and H-25. The signal of C-25 showed connectivity with that of a methyl protons at δ 0.81 attributed to H-27.
The correlation between the signal of other methyl protons at δ 0.87 and C-27 led to the assignment of H-26. The observed 1H-1H COSY correlations between the signals at δ 1.56 (H-24), δ 3.29 (H-31) and δ 3.65 corresponding to H-32, completed the assignments of the side chain. The NMR spectral data of 2 were given in Table 2.
In addition to 1 and 2, cycloartanol 3 was also isolated for the first time from Ravenala madagascariensis. It was identified from its spectral data which were in agreement with those of the literature 7, 16. It was reported to be an antidiabetic compound 7, 8. Its presence in the leaves of the plant justifies its use in traditional medicine in the treatment of diabetes.
CONCLUSION: A phytylester and two triterpenes cycloartane type were isolated from the hexane extract of the leaves of Ravenala madagascariensis. One of the triterpenes has the particularity of having two hydroxyl groups at positions 31 and 32 of its side chain. The other was identified as cycloartanol; its presence in the plant could justify the use in traditional medicine of Ravenala madagascariensis in the treatment of diabetes.
ACKNOWLEDGMENT: We are grateful to the “Centre National de Floristique” of the University Félix Houphouët-Boigny, Abidjan, Côte d’Ivoirefor the plant identification; our profound respect to the memory of Professor Aké Assi who helped us in this identification.
REFERENCES:
- Razafindraibe M, Kuhlman AR, Rabarisoa H, Rakotoarimanana V, Rajeriarison C, Rakotoarivelo N, Randrianarivony T, Rakotoarivony F,Ludovic R, Randrianasolo A and Bussmann RW: Medicinal plants used by women from Agnalazaha littoral forest (Southeastern Madagascar). Journal of Ethnobiology and Ethnomedicine 2013; 9: 73.
- Rakotoarivelo N, Razanatsima A, Rakotoarivony F, Rasoaviety L, amarosandratana AV, Jeannoda V, Kuhlman AR, Randrianasolo A and Bussmann RW: Ethnobotanical and economic value of Ravenala madagascariensis Sonn. in Eastern Madagascar. Journal of Ethnobiology and Ethnomedicine 2014; 10: 57.
- Priyadarshini SS, Vadivu R and Jayshree N: Hypolipidaemic and renoprotective study on the ethanolic and aqueous extracts of leaves of Ravenala madagascariensis Sonn., on alloxan induced diabetic rats. Journal of Pharmaceutical Sciences 2010; 2(1): 44-50.
- Jain SK and Srivastava S: Traditional uses of some Indian plants among islanders of the Indian Ocean. Indian Journal of Traditional Knowledge 2005; 45(4): 345-357.
- Priyadarsini SS, Vadivu R, Jayshree N: In vitro and In vivo antidiabetic activity of the leaves of Ravenalamadagascariensis Sonn. in alloxan induced diabetic rats. Journal of Pharmaceutical Science and Technology 2010; 2(9): 312-317.
- Ramiarantsoa H, Attioua BK, Kouamé MA. and Djakouré LA: Le O-β-D-glucoside du β-sitostérol isolé des feuilles de Ravenala madagascariensis. Journal de la Société Ouest-Africaine de Chimie 2008; 026: 99-103.
- Ragasa CY, Lin KF, Shen C-C and Raga DD: Hypoglycemic potential of triterpenes from Alstonia scholaris. Pharmaceutical Chemistry Journal 2013; 47(1): 54-57.
- Tanaka M, Misawa E, Yto Y, Habara N, Nomauchi K, Yamada M, Toida T, Hayajawa H, Takase M, Inagaki M and Higuchi R: Identification of five phytosterols from Aloe vera gel, as anti-diabetic compounds. Biological and Pharmaceutical Bulletin 2006; 29(7): 1418-1422.
- De Moraes J, De Oliveira RN, Costa JP, Junior ALG, De SousaDP, Freitas RM, Allegretti SM, and Pinto PLS: Phytol, a diterpene alcohol from chlorophyll, as a drug against neglected tropical disease Schistosomiasismansoni. PLoS Neglected Tropical Diseases 2014; 8(1): e2617.
- Upadhyay HC, Dwivedi GR, Roy S, Sharma A, Darokar MP and Srivastava SK: Phytol derivatives as drug resistance reversal agents. Chem Med Chem 2014; 9(8): 1860-1868.
- Bhattacharya AK and Rana KC: Antimycobacterial agent, (E)-phytol and lauric amide from the plant Lagasceamollis. Indian Journal of Chemistry 2013; 52B: 901-903.
- Shiao Y-J, Chen W-P and Lin Y-L: New polyphenols and triterpene from the pseudobulbs of Pleioneformasa. Journal of the Chinese Chemical Society 2009; 56: 828-833.
- Yang L, Peng C, Meng C-W, He C-J, Li X-H, Guo L, Zhou Q-M and Xiong L: A new macrolide and six cycloartane triterpenoids from the tubers of Bletillastriata. Biochemical Systematics and Ecology 2014; 57:238-241.
- Baniadam S, Rahiminejay MR, Ghannadian M, Saedi H, Ayatollahi A and Aghaei M: Cycloartane triterpenoids from Euphorbia macrostegia with their cytotoxicity against MDA-MB48 and MCF-7 cancer cell lines. Iranian Journal of Pharmaceutical Research 2014; 13(1): 135-141.
- Ayatollahi AM, Ghanadian M, Afsharypuor S, Mesaik A, Abdalla OM, Shahlaei M, Farzandi G and Mostafavi H: Cycloartanes from Euphorbia aellenii Rech. f. and their antiproliferative activity. Journal of Pharmaceutical Research 2011; 10(1): 105-112
- Suarez HC, Cuellor AC and Pita RC: Characterization of cycloatanol triterpene isolated from dichloromethane extract of Pedilanthustithymaloides. Revista Cubana de Plantas Medicinales 2011; 16(4): 347-353.
How to cite this article:
Ramiarantsoa H, Yao-Kouassi PA, Kanko C, Assi K M, Djakoure AL and Tonzibo FZ:Chemical Constituents of the Antidiabetic Plant Ravenala Madagascariensis. Int J Pharm Sci Res2014; 5(12): 5503-10.doi: 10.13040/IJPSR.0975-8232.5 (12).5503-10.
All © 2014 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
58
5503-5510
515KB
1340
English
IJPSR
H. Ramiarantsoa *, P. A. Yao-Kouassi, C. Kanko , K.M. Assi , A. L. Djakoure and F. Z. Tonzibo
Laboratoire de Chimie Organique Biologique UFR-SSMT Universite Université Félix Houphouët-Boigny, 22 BP 582, Abidjan, Côte d’Ivoire
rharisolo@yahoo.fr
13 May, 2014
29 July, 2014
19 November, 2014
http://dx.doi.org/10.13040/IJPSR.0975-8232.5(12).5503-10
01 December 2014